Recombinant HBHA boosting effect on BCG-induced immunity against mycobacterium tuberculosis infection

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Guerrero, G G ^a,b,c,d,e   Locht, C ^a,b,c,d  

^a INSERM U1019   (France)

^b CNRS   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIV LILLE   (France)

^e UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HEMAGGLUTININ; HEPARIN; MYCOBACTERIUM VACCINE; RECOMBINANT NONMETHYLATED HEPARIN BINDING HAEMAGGLUTININ; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; HEPARIN BINDING HEMAGGLUTININ; HEPARIN-BINDING HEMAGGLUTININ; LECTIN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BCG VACCINATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; IMMUNOSTIMULATION; LUNG TUBERCULOSIS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; ANIMAL; GENETICS; IMMUNIZATION; IMMUNOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; SPLEEN;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, BACTERIAL; BCG VACCINE; IMMUNIZATION, SECONDARY; LECTINS; MICE; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, SYNTHETIC;

EID: 80052733660     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/730702     Document Type: Article

References (37)

1. Maher D., Raviglione M., Global epidemiology of tuberculosis Clinics in Chest Medicine 2005 26 2 167 182
2. WHO, Annual Global Tuberculosis Control: Surveilance, Planning, Financing 2008 Geneve, Switzerland World Health Organization
3. Colditz G. A., Berkey C. S., Mosteller F., Brewer T. F., Wilson M. E., Burdick E., Fineberg H. V., The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature Pediatrics 1995 96 1 29 35
4. Andersen P., Doherty T. M., The success and failure of BCGimplications for a novel tuberculosis vaccine Nature Reviews Microbiology 2005 3 8 656 662 (Pubitemid 41052152)
5. Brooks J. V., Frank A. A., Keen M. A., Bellisle J. T., Orme I. M., Boosting vaccine for tuberculosis Infection and Immunity 2001 69 4 2714 2717 (Pubitemid 32239748)
6. Ramshaw I. A., Ramsay A. J., The prime-boost strategy: exciting prospects for improved vaccination Immunology Today 2000 21 4 163 165 (Pubitemid 30184783)
7. McShane H., Pathan A. A., Sander C. R., Keating S. M., Gilbert S. C., Huygen K., Fletcher H. A., Hill A. V. S., Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans Nature Medicine 2004 10 11 1240 1244 (Pubitemid 39540442)
8. Pathan A. A., Sander C. R., Fletcher H. A., Poulton I., Alder N. C., Beveridge N. E.R., Whelan K. T., Hill A. V.S., McShane H., Boosting BCG with recombinant modified vaccinia Ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials PLoS One 2007 2 10
9. Goonetilleke N. P., McShane H., Hannan C. M., Anderson R. J., Brookes R. H., Hill A. V. S., Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara Journal of Immunology 2003 171 3 1602 1609 (Pubitemid 36900097)
10. Doherty T. M., Dietrich J., Billeskov R., Tuberculosis subunit vaccines: from basic science to clinical testing Expert Opinion on Biological Therapy 2007 7 10 1539 1549 (Pubitemid 47597142)
11. Ly L. H., McMurray D. N., Tuberculosis: vaccines in the pipeline Expert Review of Vaccines 2008 7 5 635 650 (Pubitemid 351881346)
12. Flynn J. L., Chang J., Immunology of tuberculosis Annual Review of Immunology 2001 19 93 129 (Pubitemid 32368031)
13. North R. J., Jung Y. J., Immunity to tuberculosis Annual Review of Immunology 2004 22 599 623 (Pubitemid 38680435)
14. Dietrich J., Doherty T. M., Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development APMIS 2009 117 5-6 440 457
15. Menozzi F. D., Rouse J. H., Alavi M., Lande-Sharp M., Muller J., Bischoff R., Brennan M. J., Locht C., Identification of a heparin-binding hemagglutinin present in mycobacteria Journal of Experimental Medicine 1996 184 3 993 1001
16. Menozzi F. D., Bischoff R., Fort E., Brennan M. J., Locht C., Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin Proceedings of the National Academy of Sciences of the United States of America 1998 95 21 12625 12630 (Pubitemid 28483815)
17. Temmerman S., Pethe K., Parra M., Alonso S., Rouanet C., Pickett T., Drowart A., Debrie A. S., Delogu G., Menozzi F. D., Sergheraert C., Brennan M. J., Mascart F., Locht C., Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin Nature Medicine 2004 10 9 935 941 (Pubitemid 39273734)
18. Parra M., Pickett T., Delogu G., Dheenadhayalan V., Debrie A. S., Locht C., Brennan M. J., The mycobacterial heparin-binding hemagglutinin is a protective antigen in the mouse aerosol challenge model of tuberculosis Infection and Immunity 2004 72 12 6799 6805 (Pubitemid 39552347)
19. Locht C., Hougardy J. M., Rouanet C., Place S., Mascart F., Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis Tuberculosis 2006 86 3-4 303 309
20. Cooper J. A., Hayman W., Reed C., Kagawa H., Good M. F., Saul A., Mapping of conformational B cell epitopes within alpha-helical coiled coil proteins Molecular Immunology 1997 34 6 433 440 (Pubitemid 27373709)
21. Sundaram R., Lynch M. P., Rawale S. V., Sun Y., Kazanji M., Kaumaya P. T. P., De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies Journal of Biological Chemistry 2004 279 23 24141 24151 (Pubitemid 38725274)
22. Guerrero G. G., Feunou P., Locht C., The coiled-coil N-terminal domain of the heparin-binding haemagglutinin is required for the humoral and cellular immune responses in mice Molecular Immunology 2008 46 1 116 124
23. Guerrero G. G., Debrie A. S., Locht C., Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis Vaccine 2010 28 27 4340 4347
24. Masungi C., Temmerman S., Van Vooren J. P., Drowart A., Pethe K., Menozzi F. D., Locht C., Mascart F., Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis Journal of Infectious Diseases 2002 185 4 513 520 (Pubitemid 34142814)
25. Khader S. A., Bell G. K., Pearl J. E., Fountain J. J., Rangel-Moreno J., Cilley G. E., Shen F., Eaton S. M., Gaffen S. L., Swain S. L., Locksley R. M., Haynes L., Randall T. D., Cooper A. M., IL-23 and IL-17 in the establishment of protective pulmonary CD4 + T cell responses after vaccination and during Mycobacterium tuberculosis challenge Nature Immunology 2007 8 4 369 377 (Pubitemid 46745412)
26. Cooper A. M., Solache A., Khader S. A., Interleukin-12 and tuberculosis: an old story revisited Current Opinion in Immunology 2007 19 4 441 447 (Pubitemid 47284862)
27. Feng C. G., Jankovic D., Kullberg M., Cheever A., Scanga C. A., Hieny S., Caspar P., Yap G. S., Sher A., Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production Journal of Immunology 2005 174 7 4185 4192 (Pubitemid 40395997)
28. Wu C. Y., Kirman J. R., Rotte M. J., Davey D. F., Perfetto S. P., Rhee E. G., Freidag B. L., Hill B. J., Douek D. C., Seder R. A., Distinct lineages of TH1 cells have differential capacities for memory cell generation in vivo Nature Immunology 2002 3 9 852 858
29. Goldsack L., Kirman J. R., Half-truths and selective memory: interferon gamma, CD4 + T cells and protective memory against tuberculosis Tuberculosis 2007 87 6 465 473 (Pubitemid 47589039)
30. Jung Y. J., Ryan L., Lacourse R., North R. J., Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice Immunology 2003 109 2 295 299 (Pubitemid 36683621)
31. Darrah P. A., Hegde S. T., Patel D. T., Lindsay R. W. B., Chen L., Roederer M., Seder R. A., IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform Journal of Experimental Medicine 2010 207 7 1421 1433
32. Shafiani S., Tucker-Heard G., Kariyone A., Takatsu K., Urdahl K. B., Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis Journal of Experimental Medicine 2010 207 7 1409 1420
33. Junqueira-Kipnis A. P., Turner J., Gonzalez-Juarrero M., Turner O. C., Orme I. M., Stable T-cell population expressing an effector cell surface phenotype in the lungs of mice chronically infected with Mycobacterium tuberculosis Infection and Immunity 2004 72 1 570 575 (Pubitemid 38018218)
34. Cooper A. M., Cell-mediated immune responses in tuberculosis Annual Review of Immunology 2009 27 393 422
35. Seder R. A., Darrah P. A., Roederer M., T-cell quality in memory and protection: implications for vaccine design Nature Reviews Immunology 2008 8 4 247 258 (Pubitemid 351432801)
36. Majlessi L., Simsova M., Jarvis Z., Brodin P., Rojas M. J., Bauche C., Nouzé C., Ladant D., Cole S. T., Sebo P., Leclerc C., An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis Infection and Immunity 2006 74 4 2128 2137
37. Badell E., Nicolle F., Clark S., Majlessi L., Boudou F., Martino A., Castello-Branco L., Leclerc C., Lewis D. J. M., Marsh P. D., Gicquel B., Winter N., Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN- producing T-cells Vaccine 2009 27 1 28 37